• Je něco špatně v tomto záznamu ?

Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones

Z. Vojtechova, I. Sabol, M. Salakova, J. Smahelova, J. Zavadil, L. Turek, M. Grega, J. Klozar, B. Prochazka, R. Tachezy,

. 2016 ; 16 (-) : 382. [pub] 20160704

Jazyk angličtina Země Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017176

BACKGROUND: Better insights into the molecular changes involved in virus-associated and -independent head and neck cancer may advance our knowledge of HNC carcinogenesis and identify critical disease biomarkers. Here we aimed to characterize the expression profiles in a matched set of well-characterized HPV-dependent and HPV-independent tonsillar tumors and equivalent immortalized keratinocyte clones to define potential and clinically relevant biomarkers of HNC of different etiology. METHODS: Fresh frozen tonsillar cancer tissues were analyzed together with non-malignant tonsillar tissues and compared with cervical tumors and normal cervical tissues. Furthermore, relative miRNAs abundance levels of primary and immortalized human keratinocyte clones were evaluated. The global quantitation of miRNA gene abundance was performed using a TaqMan Low Density Array system. The confirmation of differentially expressed miRNAs was performed on a set of formalin-fixed paraffin-embedded tumor samples enriched for the tumor cell fraction by macrodissection. RESULTS: We defined 46 upregulated and 31 downregulated miRNAs characteristic for the HPV-positive tonsillar tumors and 42 upregulated miRNAs and 42 downregulated miRNAs characteristic for HPV-independent tumors. In comparison with the expression profiles in cervical tumors, we defined miR-141-3p, miR-15b-5p, miR-200a-3p, miR-302c-3p, and miR-9-5p as specific for HPV induced malignancies. MiR-335-5p, miR-579-3p, and miR-126-5p were shared by the expression profiles of HPV-positive tonsillar tumors and of the HPV immortalized keratinocyte clones, whereas miR-328-3p, miR-34c-3p, and miR-885-5p were shared by the miRNA profiles of HPV-negative tonsillar tumors and the HPV-negative keratinocytes. CONCLUSIONS: We identified the miRNAs characteristic for HPV-induced tumors and tonsillar tumors of different etiology, and the results were compared with those of the model system. Our report presents the basis for further investigations leading to the identification of clinically relevant diagnostic and/or therapeutic biomarkers for tumors of viral and non-viral etiology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017176
003      
CZ-PrNML
005      
20180517093733.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-016-2430-y $2 doi
035    __
$a (PubMed)27377959
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vojtechova, Zuzana $u Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic. Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic.
245    10
$a Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones / $c Z. Vojtechova, I. Sabol, M. Salakova, J. Smahelova, J. Zavadil, L. Turek, M. Grega, J. Klozar, B. Prochazka, R. Tachezy,
520    9_
$a BACKGROUND: Better insights into the molecular changes involved in virus-associated and -independent head and neck cancer may advance our knowledge of HNC carcinogenesis and identify critical disease biomarkers. Here we aimed to characterize the expression profiles in a matched set of well-characterized HPV-dependent and HPV-independent tonsillar tumors and equivalent immortalized keratinocyte clones to define potential and clinically relevant biomarkers of HNC of different etiology. METHODS: Fresh frozen tonsillar cancer tissues were analyzed together with non-malignant tonsillar tissues and compared with cervical tumors and normal cervical tissues. Furthermore, relative miRNAs abundance levels of primary and immortalized human keratinocyte clones were evaluated. The global quantitation of miRNA gene abundance was performed using a TaqMan Low Density Array system. The confirmation of differentially expressed miRNAs was performed on a set of formalin-fixed paraffin-embedded tumor samples enriched for the tumor cell fraction by macrodissection. RESULTS: We defined 46 upregulated and 31 downregulated miRNAs characteristic for the HPV-positive tonsillar tumors and 42 upregulated miRNAs and 42 downregulated miRNAs characteristic for HPV-independent tumors. In comparison with the expression profiles in cervical tumors, we defined miR-141-3p, miR-15b-5p, miR-200a-3p, miR-302c-3p, and miR-9-5p as specific for HPV induced malignancies. MiR-335-5p, miR-579-3p, and miR-126-5p were shared by the expression profiles of HPV-positive tonsillar tumors and of the HPV immortalized keratinocyte clones, whereas miR-328-3p, miR-34c-3p, and miR-885-5p were shared by the miRNA profiles of HPV-negative tonsillar tumors and the HPV-negative keratinocytes. CONCLUSIONS: We identified the miRNAs characteristic for HPV-induced tumors and tonsillar tumors of different etiology, and the results were compared with those of the model system. Our report presents the basis for further investigations leading to the identification of clinically relevant diagnostic and/or therapeutic biomarkers for tumors of viral and non-viral etiology.
650    _2
$a kultivované buňky $7 D002478
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a genové regulační sítě $7 D053263
650    _2
$a lidé $7 D006801
650    _2
$a keratinocyty $x cytologie $x patologie $7 D015603
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a infekce papilomavirem $x genetika $7 D030361
650    _2
$a analýza hlavních komponent $7 D025341
650    _2
$a tonzilární nádory $x genetika $x virologie $7 D014067
650    _2
$a nádory děložního čípku $x genetika $x virologie $7 D002583
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sabol, Ivan $u Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic.
700    1_
$a Salakova, Martina $u Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic. Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic.
700    1_
$a Smahelova, Jana $u Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic. Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic.
700    1_
$a Zavadil, Jiri $u Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, Lyon, France.
700    1_
$a Turek, Lubomir $u Veterans Affairs Healthcare System and Department of Pathology, University of Iowa, Iowa City, IA, USA.
700    1_
$a Grega, Marek $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Klozar, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Prochazka, Bohumir $u Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic.
700    1_
$a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic. rutach@uhkt.cz. Department of Immunology, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, Prague 2, CZ-12820, Czech Republic. rutach@uhkt.cz.
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 16, č. - (2016), s. 382
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27377959 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517093909 $b ABA008
999    __
$a ok $b bmc $g 1300800 $s 1014016
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c - $d 382 $e 20160704 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace